GlassScriptPhysician profile
Matthew Pilecki
NPI 1033508981
$28,695.54
in general payments reported to CMS, 2019-2025
37 companies · $6,507 in 2025
The $6,507 reported for 2025 was more than what 92% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2021: $328 · 2022: $13K · 2023: $2,270 · 2024: $6,166 · 2025: $6,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,562 · Travel and Lodging: $6,481 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,562.47 |
| Travel and Lodging | $6,481.31 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,794.27 | 2022-2025 | Superion Indirect Decompression System, Intracept, Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $2,821.78 | 2024-2025 | Iovera |
| Medtronic, INC. | $2,535.90 | 2022-2025 | Interstim, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Stryker Corporation | $1,647.61 | 2023-2025 | Augment Injectable, Omnicurve, Spinejack |
| Mml US, INC. | $1,359.78 | 2023-2025 | Reactiv8 |
| Abbott Laboratories | $1,339.27 | 2022-2025 | Proclaim, Prodigy, Eterna |
| Lenoss Medical INC | $745.80 | 2025 | Osteopearl |
| Spr Therapeutics, INC | $687.58 | 2023-2025 | Sprint Pns System |
| Nevro Corp. | $645.79 | 2022-2023 | Senza |
| Spinal Simplicity, LLC | $554.80 | 2023-2025 | Ha Minuteman G3-R |
| Relievant Medsystems, INC. | $375.06 | 2023 | Intracept |
| Janssen Scientific Affairs, LLC | $298.02 | 2019-2022 | |
| Painteq LLC | $237.17 | 2023 | Painteq |
| Averitas Pharma INC. | $229.49 | 2023-2025 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $218.85 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $217.37 | 2024-2025 | Evenity, Prolia, Prolia |
| Curonix LLC | $198.78 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $150.00 | 2023 | Mild Device Kit |
| Avanos Medical | $149.81 | 2025 | Coolief Cooled Radiofrequency, Generator |
| Janssen Biotech, INC. | $142.25 | 2023 | Stelara |
| Saluda Medical Americas, INC. | $142.14 | 2024 | Evoke |
| Biotronik Nro, INC. | $127.39 | 2025 | Prospera |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.64 | 2021 | |
| Gilead Sciences, INC. | $120.89 | 2023 | Vemlidy |
| Si-Bone, INC. | $117.01 | 2025 | |
| Exelixis INC. | $112.76 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $108.93 | 2025 | |
| Alexion Pharmaceuticals, INC. | $96.78 | 2025 | Strensiq |
| Tersera Therapeutics LLC | $74.44 | 2024-2025 | Prialt |
| Convatec INC. | $63.07 | 2025 | |
| Globus Medical, INC. | $54.65 | 2025 | Senza |
| Abbvie INC. | $52.09 | 2023-2024 | |
| Bioventus LLC | $51.29 | 2022-2023 | Stimrouter Implantable Kit |
| Depuy Synthes Sales INC. | $46.73 | 2024-2025 | Monovisc, Orthovisc, Peak |
| Becton, Dickinson and Company | $22.67 | 2025 | Accucath |
| Stratus Medical, LLC | $20.89 | 2023 | Nimbus |
| Great Lakes Orthopedics | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Pilecki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.